AngioDynamics Inc logo

ANGOAngioDynamics Inc

NASDAQ · Healthcare · Medical Instruments & Supplies

$16.12

+$0.26 (+1.64%)

AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on NASDAQ. It is led by James C. Clemmer, based in 14 Plaza Drive, Latham, NY, United States, 12110, with about 748 employees. AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

Latest reported ANGO revenue for 2025-08-31 was $75.7M. Net income was -$10.9M. Revenue was down 74.1% from 2025-05-31 to 2025-08-31. ANGO currently screens at market cap $378.5M.

Use this ANGO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ANGO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ANGO SEC filings page. Lician reads the product cache first so this HTML stays unique to AngioDynamics Inc even when a live quote feed is slow.

About AngioDynamics Inc

AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York.

ANGO Key Statistics

Market Cap

$378.46M

Volume

179,113

Previous Close

$15.75

Day Range

$15.54$15.79

00

EPS

-$0.83

Revenue

$292.50M

Net Income

-$33.99M

Gross Profit

$0.00

Free Cash Flow

$0.00

Revenue Growth

-3.8%

Profit Margin

-11.6%

Employees

748

ANGO Financials

Annual income statement in USD. Latest reported periods first.

ANGO annual income statement across FY2025, FY2024, FY2023, FY2022
LineFY2025FY2024FY2023FY2022
Revenue$292.50M$303.91M$338.75M$316.22M
Cost of Revenue$0.00$0.00$0.00$0.00
Gross Profit$0.00$0.00$0.00$0.00
Operating Income$0.00$0.00$0.00$0.00
Net Income-$33.99M-$184.35M-$52.44M-$26.55M
EPS (Diluted)-$0.83-$4.59-$1.33-$0.68

Total Assets

$280.14M

Total Debt

$0.00

Shareholders' Equity

$0.00

Cash & Equivalents

$55.89M

Operating Cash Flow

-$10.13M

Free Cash Flow

$0.00

AngioDynamics Inc Company Information

CEO, President & Director
James C. Clemmer
Headquarters
14 Plaza Drive, Latham, NY, United States, 12110
Phone
518 795 1400
IPO / Founded
2004-05-27
Industry
Medical Instruments & Supplies
Data Updated:

Upcoming Events for ANGO